Estévez RY, Estévez RM, Martínez HL, Quintero VI

Language: Spanish
References: 10
Page: 232-236
PDF size: 679.57 Kb.

ABSTRACT

Dilated cardiomyopathy in pregnancy is generally of unknown origin, but in 20-35% it is hereditary. Here is presented the case of a 22-year-old patient, 34.6 weeks of pregnancy, primipara, with a history of slight bronchial asthma, who was asymptomatic from the cardiovascular point of view, until a heart rate greater than 130 beats per minute and edema in lower limbs were found, which were the causes that bring her to the Department of Cardiology. The transthoracic echocardiogram revealed dilated cardiomyopathy with severely depressed left ventricular function, diastolic dysfunction, severe tricuspid and moderate mitral regurgitations, as well as slight pulmonary hypertension. It was considered a very high obstetric risk (group IV of the World Health Organization Classification) and, after coordinating with the national department of heart disease and pregnancy, the patient was sent to the reference center, where a cesarean section was performed without complications.

REFERENCES

1. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald, Tratado de Cardiología: Texto de medicina cardiovascular. 10Ş ed. Barcelona: Elsevier; 2015. p. 1755-67.

2. Hilfiker-Kleiner D, Haghikia A, Masuko D, Nonhoff J, Held D, et al. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail. 2017;19(12):1723-8.

3. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374(3):233-41.

4. Grewal J, Siu SC, Ross HJ, Mason J, Balint OH, Sermer M, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol. 2009;55(1):45-52.

5. Blauwet LA, Delgado-Montero A, Ryo K, Marek JJ, Alharethi R, Mather PJ, et al. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes. Circ Heart Fail [Internet]. 2016 [citado 27/04/2019];9(5):e002756. Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.115.002756

6. Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096-105.

7. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200.

8. Hilfiker-Kleiner D, Westhoff-Bleck M, Gunter HH, von Kaisenberg CS, Bohnhorst B, Hoeltje M, et al. A management algorithm for acute heart failure in pregnancy. The Hannover experience. Eur Heart J. 2015;36(13):769-70.

9. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35(32):2165-73.

10. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol. 2019;72(2):161.e1-e65.